Analystreport

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) had its price target lowered by analysts at Truist Financial Co. from $40.00 to $35.00.

Marinus Pharmaceuticals, Inc.  (MRNS) 
Last marinus pharmaceuticals, inc. earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.marinuspharma.com/investor-relations